Status:
COMPLETED
The Research Registry for Neonatal Lupus
Lead Sponsor:
NYU Langone Health
Conditions:
Neonatal Lupus
Systemic Lupus Erythematosus
Eligibility:
All Genders
Brief Summary
Women with lupus and other related disorders produce certain antibodies in the blood. Some women have these antibodies even if they have not yet developed symptoms of lupus or Sjogren's syndrome. When...
Detailed Description
Neonatal lupus is a disease seen in babies born to mothers who have antibodies to SSA/Ro and/or SSB/La proteins. The mother may have systemic lupus erythematosus, Sjogren's syndrome, or be otherwise h...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Mother with antibodies to SSA/Ro, SSB/La, or ribonucleoproteins (RNP) OR Child of mother with such antibodies who has neonatal lupus (congenital heart block, transient skin rash, and/or hepatic or hematologic manifestations) OR Father of neonatal lupus-affected child OR Maternal grandparents of neonatal lupus-affected child OR Maternal aunts and uncles of neonatal lupus-affected OR Unaffected siblings of neonatal lupus-affected child
Exclusion
Key Trial Info
Start Date :
May 27 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2016
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00074373
Start Date
May 27 2010
End Date
June 1 2016
Last Update
August 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jill P. Buyon, MD
New York, New York, United States, 10016